Answers are grounded in this paper and cite their sources.
We aimed to evaluate factors that influence changes in blood low-density lipoprotein cholesterol (LDL-C) levels after treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitors in Japanese patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Imada et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: